2B: Biomaterial-Mediated Immune Modulation for Autoimmunity Treatment

Autoimmune diseases, including multiple sclerosis and rheumatoid arthritis, affect over 24 million Americans and are among the leading causes of disability and death in the United States, disproportionately impacting women. A broad spectrum of biomaterials has been engineered to address autoimmunity by modulating immune responses via several mechanisms, such as delivering immunosuppressive drugs, inducing anti-inflammatory reactions, and enhancing regulatory immune cell functions. The proposed session aims to showcase recent studies that utilize biomaterial design to foster tolerogenic responses in the treatment of autoimmune and inflammatory conditions.